Global Biologics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Biologics market size was valued at USD 107170 million in 2023 and is forecast to a readjusted size of USD 150730 million by 2030 with a CAGR of 5.0% during review period.
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
The Global Info Research report includes an overview of the development of the Biologics industry chain, the market status of Infectious Diseases (Monoclonal Antibodies, Vaccines), Oncology (Monoclonal Antibodies, Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biologics.
Regionally, the report analyzes the Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biologics market.
Regional Analysis: The report involves examining the Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biologics:
Company Analysis: Report covers individual Biologics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infectious Diseases, Oncology).
Technology Analysis: Report covers specific technologies relevant to Biologics. It assesses the current state, advancements, and potential future developments in Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biologics, with price, sales, revenue and global market share of Biologics from 2019 to 2024.
Chapter 3, the Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biologics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biologics.
Chapter 14 and 15, to describe Biologics sales channel, distributors, customers, research findings and conclusion.
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
The Global Info Research report includes an overview of the development of the Biologics industry chain, the market status of Infectious Diseases (Monoclonal Antibodies, Vaccines), Oncology (Monoclonal Antibodies, Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biologics.
Regionally, the report analyzes the Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biologics market.
Regional Analysis: The report involves examining the Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biologics:
Company Analysis: Report covers individual Biologics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Infectious Diseases, Oncology).
Technology Analysis: Report covers specific technologies relevant to Biologics. It assesses the current state, advancements, and potential future developments in Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Antisense
- RNAi
- Infectious Diseases
- Oncology
- Immunology
- Autoimmune Diseases
- Eli Lilly & Company
- Samsung Biologics
- F Hoffman La Roche
- Celltrion
- Addgene
- Amgen
- Abbvie Inc.
- Sanofi
- Pfizer Inc.
- Merck & Co. Inc.
- Novo Nordisk A/S
- Johnson & Johnson Services Inc.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biologics, with price, sales, revenue and global market share of Biologics from 2019 to 2024.
Chapter 3, the Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biologics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biologics.
Chapter 14 and 15, to describe Biologics sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biologics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Monoclonal Antibodies
1.3.3 Vaccines
1.3.4 Recombinant Proteins
1.3.5 Antisense
1.3.6 RNAi
1.4 Market Analysis by Application
1.4.1 Overview: Global Biologics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Infectious Diseases
1.4.3 Oncology
1.4.4 Immunology
1.4.5 Autoimmune Diseases
1.5 Global Biologics Market Size & Forecast
1.5.1 Global Biologics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Biologics Sales Quantity (2019-2030)
1.5.3 Global Biologics Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Eli Lilly & Company
2.1.1 Eli Lilly & Company Details
2.1.2 Eli Lilly & Company Major Business
2.1.3 Eli Lilly & Company Biologics Product and Services
2.1.4 Eli Lilly & Company Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Eli Lilly & Company Recent Developments/Updates
2.2 Samsung Biologics
2.2.1 Samsung Biologics Details
2.2.2 Samsung Biologics Major Business
2.2.3 Samsung Biologics Biologics Product and Services
2.2.4 Samsung Biologics Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Samsung Biologics Recent Developments/Updates
2.3 F Hoffman La Roche
2.3.1 F Hoffman La Roche Details
2.3.2 F Hoffman La Roche Major Business
2.3.3 F Hoffman La Roche Biologics Product and Services
2.3.4 F Hoffman La Roche Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 F Hoffman La Roche Recent Developments/Updates
2.4 Celltrion
2.4.1 Celltrion Details
2.4.2 Celltrion Major Business
2.4.3 Celltrion Biologics Product and Services
2.4.4 Celltrion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Celltrion Recent Developments/Updates
2.5 Addgene
2.5.1 Addgene Details
2.5.2 Addgene Major Business
2.5.3 Addgene Biologics Product and Services
2.5.4 Addgene Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Addgene Recent Developments/Updates
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Biologics Product and Services
2.6.4 Amgen Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Amgen Recent Developments/Updates
2.7 Abbvie Inc.
2.7.1 Abbvie Inc. Details
2.7.2 Abbvie Inc. Major Business
2.7.3 Abbvie Inc. Biologics Product and Services
2.7.4 Abbvie Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbvie Inc. Recent Developments/Updates
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Biologics Product and Services
2.8.4 Sanofi Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sanofi Recent Developments/Updates
2.9 Pfizer Inc.
2.9.1 Pfizer Inc. Details
2.9.2 Pfizer Inc. Major Business
2.9.3 Pfizer Inc. Biologics Product and Services
2.9.4 Pfizer Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Pfizer Inc. Recent Developments/Updates
2.10 Merck & Co. Inc.
2.10.1 Merck & Co. Inc. Details
2.10.2 Merck & Co. Inc. Major Business
2.10.3 Merck & Co. Inc. Biologics Product and Services
2.10.4 Merck & Co. Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Merck & Co. Inc. Recent Developments/Updates
2.11 Novo Nordisk A/S
2.11.1 Novo Nordisk A/S Details
2.11.2 Novo Nordisk A/S Major Business
2.11.3 Novo Nordisk A/S Biologics Product and Services
2.11.4 Novo Nordisk A/S Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Novo Nordisk A/S Recent Developments/Updates
2.12 Johnson & Johnson Services Inc.
2.12.1 Johnson & Johnson Services Inc. Details
2.12.2 Johnson & Johnson Services Inc. Major Business
2.12.3 Johnson & Johnson Services Inc. Biologics Product and Services
2.12.4 Johnson & Johnson Services Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Johnson & Johnson Services Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGICS BY MANUFACTURER
3.1 Global Biologics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Biologics Revenue by Manufacturer (2019-2024)
3.3 Global Biologics Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Biologics Manufacturer Market Share in 2023
3.4.2 Top 6 Biologics Manufacturer Market Share in 2023
3.5 Biologics Market: Overall Company Footprint Analysis
3.5.1 Biologics Market: Region Footprint
3.5.2 Biologics Market: Company Product Type Footprint
3.5.3 Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biologics Market Size by Region
4.1.1 Global Biologics Sales Quantity by Region (2019-2030)
4.1.2 Global Biologics Consumption Value by Region (2019-2030)
4.1.3 Global Biologics Average Price by Region (2019-2030)
4.2 North America Biologics Consumption Value (2019-2030)
4.3 Europe Biologics Consumption Value (2019-2030)
4.4 Asia-Pacific Biologics Consumption Value (2019-2030)
4.5 South America Biologics Consumption Value (2019-2030)
4.6 Middle East and Africa Biologics Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Biologics Sales Quantity by Type (2019-2030)
5.2 Global Biologics Consumption Value by Type (2019-2030)
5.3 Global Biologics Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biologics Sales Quantity by Application (2019-2030)
6.2 Global Biologics Consumption Value by Application (2019-2030)
6.3 Global Biologics Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Biologics Sales Quantity by Type (2019-2030)
7.2 North America Biologics Sales Quantity by Application (2019-2030)
7.3 North America Biologics Market Size by Country
7.3.1 North America Biologics Sales Quantity by Country (2019-2030)
7.3.2 North America Biologics Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Biologics Sales Quantity by Type (2019-2030)
8.2 Europe Biologics Sales Quantity by Application (2019-2030)
8.3 Europe Biologics Market Size by Country
8.3.1 Europe Biologics Sales Quantity by Country (2019-2030)
8.3.2 Europe Biologics Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biologics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Biologics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Biologics Market Size by Region
9.3.1 Asia-Pacific Biologics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Biologics Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Biologics Sales Quantity by Type (2019-2030)
10.2 South America Biologics Sales Quantity by Application (2019-2030)
10.3 South America Biologics Market Size by Country
10.3.1 South America Biologics Sales Quantity by Country (2019-2030)
10.3.2 South America Biologics Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biologics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Biologics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Biologics Market Size by Country
11.3.1 Middle East & Africa Biologics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Biologics Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Biologics Market Drivers
12.2 Biologics Market Restraints
12.3 Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biologics
13.3 Biologics Production Process
13.4 Biologics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biologics Typical Distributors
14.3 Biologics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biologics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Monoclonal Antibodies
1.3.3 Vaccines
1.3.4 Recombinant Proteins
1.3.5 Antisense
1.3.6 RNAi
1.4 Market Analysis by Application
1.4.1 Overview: Global Biologics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Infectious Diseases
1.4.3 Oncology
1.4.4 Immunology
1.4.5 Autoimmune Diseases
1.5 Global Biologics Market Size & Forecast
1.5.1 Global Biologics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Biologics Sales Quantity (2019-2030)
1.5.3 Global Biologics Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Eli Lilly & Company
2.1.1 Eli Lilly & Company Details
2.1.2 Eli Lilly & Company Major Business
2.1.3 Eli Lilly & Company Biologics Product and Services
2.1.4 Eli Lilly & Company Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Eli Lilly & Company Recent Developments/Updates
2.2 Samsung Biologics
2.2.1 Samsung Biologics Details
2.2.2 Samsung Biologics Major Business
2.2.3 Samsung Biologics Biologics Product and Services
2.2.4 Samsung Biologics Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Samsung Biologics Recent Developments/Updates
2.3 F Hoffman La Roche
2.3.1 F Hoffman La Roche Details
2.3.2 F Hoffman La Roche Major Business
2.3.3 F Hoffman La Roche Biologics Product and Services
2.3.4 F Hoffman La Roche Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 F Hoffman La Roche Recent Developments/Updates
2.4 Celltrion
2.4.1 Celltrion Details
2.4.2 Celltrion Major Business
2.4.3 Celltrion Biologics Product and Services
2.4.4 Celltrion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Celltrion Recent Developments/Updates
2.5 Addgene
2.5.1 Addgene Details
2.5.2 Addgene Major Business
2.5.3 Addgene Biologics Product and Services
2.5.4 Addgene Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Addgene Recent Developments/Updates
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Biologics Product and Services
2.6.4 Amgen Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Amgen Recent Developments/Updates
2.7 Abbvie Inc.
2.7.1 Abbvie Inc. Details
2.7.2 Abbvie Inc. Major Business
2.7.3 Abbvie Inc. Biologics Product and Services
2.7.4 Abbvie Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbvie Inc. Recent Developments/Updates
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Biologics Product and Services
2.8.4 Sanofi Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sanofi Recent Developments/Updates
2.9 Pfizer Inc.
2.9.1 Pfizer Inc. Details
2.9.2 Pfizer Inc. Major Business
2.9.3 Pfizer Inc. Biologics Product and Services
2.9.4 Pfizer Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Pfizer Inc. Recent Developments/Updates
2.10 Merck & Co. Inc.
2.10.1 Merck & Co. Inc. Details
2.10.2 Merck & Co. Inc. Major Business
2.10.3 Merck & Co. Inc. Biologics Product and Services
2.10.4 Merck & Co. Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Merck & Co. Inc. Recent Developments/Updates
2.11 Novo Nordisk A/S
2.11.1 Novo Nordisk A/S Details
2.11.2 Novo Nordisk A/S Major Business
2.11.3 Novo Nordisk A/S Biologics Product and Services
2.11.4 Novo Nordisk A/S Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Novo Nordisk A/S Recent Developments/Updates
2.12 Johnson & Johnson Services Inc.
2.12.1 Johnson & Johnson Services Inc. Details
2.12.2 Johnson & Johnson Services Inc. Major Business
2.12.3 Johnson & Johnson Services Inc. Biologics Product and Services
2.12.4 Johnson & Johnson Services Inc. Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Johnson & Johnson Services Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGICS BY MANUFACTURER
3.1 Global Biologics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Biologics Revenue by Manufacturer (2019-2024)
3.3 Global Biologics Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Biologics Manufacturer Market Share in 2023
3.4.2 Top 6 Biologics Manufacturer Market Share in 2023
3.5 Biologics Market: Overall Company Footprint Analysis
3.5.1 Biologics Market: Region Footprint
3.5.2 Biologics Market: Company Product Type Footprint
3.5.3 Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biologics Market Size by Region
4.1.1 Global Biologics Sales Quantity by Region (2019-2030)
4.1.2 Global Biologics Consumption Value by Region (2019-2030)
4.1.3 Global Biologics Average Price by Region (2019-2030)
4.2 North America Biologics Consumption Value (2019-2030)
4.3 Europe Biologics Consumption Value (2019-2030)
4.4 Asia-Pacific Biologics Consumption Value (2019-2030)
4.5 South America Biologics Consumption Value (2019-2030)
4.6 Middle East and Africa Biologics Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Biologics Sales Quantity by Type (2019-2030)
5.2 Global Biologics Consumption Value by Type (2019-2030)
5.3 Global Biologics Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biologics Sales Quantity by Application (2019-2030)
6.2 Global Biologics Consumption Value by Application (2019-2030)
6.3 Global Biologics Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Biologics Sales Quantity by Type (2019-2030)
7.2 North America Biologics Sales Quantity by Application (2019-2030)
7.3 North America Biologics Market Size by Country
7.3.1 North America Biologics Sales Quantity by Country (2019-2030)
7.3.2 North America Biologics Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Biologics Sales Quantity by Type (2019-2030)
8.2 Europe Biologics Sales Quantity by Application (2019-2030)
8.3 Europe Biologics Market Size by Country
8.3.1 Europe Biologics Sales Quantity by Country (2019-2030)
8.3.2 Europe Biologics Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biologics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Biologics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Biologics Market Size by Region
9.3.1 Asia-Pacific Biologics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Biologics Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Biologics Sales Quantity by Type (2019-2030)
10.2 South America Biologics Sales Quantity by Application (2019-2030)
10.3 South America Biologics Market Size by Country
10.3.1 South America Biologics Sales Quantity by Country (2019-2030)
10.3.2 South America Biologics Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biologics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Biologics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Biologics Market Size by Country
11.3.1 Middle East & Africa Biologics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Biologics Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Biologics Market Drivers
12.2 Biologics Market Restraints
12.3 Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biologics
13.3 Biologics Production Process
13.4 Biologics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biologics Typical Distributors
14.3 Biologics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 2. Global Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Eli Lilly & Company Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly & Company Major Business
Table 5. Eli Lilly & Company Biologics Product and Services
Table 6. Eli Lilly & Company Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Eli Lilly & Company Recent Developments/Updates
Table 8. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 9. Samsung Biologics Major Business
Table 10. Samsung Biologics Biologics Product and Services
Table 11. Samsung Biologics Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Samsung Biologics Recent Developments/Updates
Table 13. F Hoffman La Roche Basic Information, Manufacturing Base and Competitors
Table 14. F Hoffman La Roche Major Business
Table 15. F Hoffman La Roche Biologics Product and Services
Table 16. F Hoffman La Roche Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. F Hoffman La Roche Recent Developments/Updates
Table 18. Celltrion Basic Information, Manufacturing Base and Competitors
Table 19. Celltrion Major Business
Table 20. Celltrion Biologics Product and Services
Table 21. Celltrion Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Celltrion Recent Developments/Updates
Table 23. Addgene Basic Information, Manufacturing Base and Competitors
Table 24. Addgene Major Business
Table 25. Addgene Biologics Product and Services
Table 26. Addgene Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Addgene Recent Developments/Updates
Table 28. Amgen Basic Information, Manufacturing Base and Competitors
Table 29. Amgen Major Business
Table 30. Amgen Biologics Product and Services
Table 31. Amgen Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Amgen Recent Developments/Updates
Table 33. Abbvie Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Abbvie Inc. Major Business
Table 35. Abbvie Inc. Biologics Product and Services
Table 36. Abbvie Inc. Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Abbvie Inc. Recent Developments/Updates
Table 38. Sanofi Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Biologics Product and Services
Table 41. Sanofi Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sanofi Recent Developments/Updates
Table 43. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Inc. Major Business
Table 45. Pfizer Inc. Biologics Product and Services
Table 46. Pfizer Inc. Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Pfizer Inc. Recent Developments/Updates
Table 48. Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Merck & Co. Inc. Major Business
Table 50. Merck & Co. Inc. Biologics Product and Services
Table 51. Merck & Co. Inc. Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Merck & Co. Inc. Recent Developments/Updates
Table 53. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 54. Novo Nordisk A/S Major Business
Table 55. Novo Nordisk A/S Biologics Product and Services
Table 56. Novo Nordisk A/S Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Novo Nordisk A/S Recent Developments/Updates
Table 58. Johnson & Johnson Services Inc. Basic Information, Manufacturing Base and Competitors
Table 59. Johnson & Johnson Services Inc. Major Business
Table 60. Johnson & Johnson Services Inc. Biologics Product and Services
Table 61. Johnson & Johnson Services Inc. Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Johnson & Johnson Services Inc. Recent Developments/Updates
Table 63. Global Biologics Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 64. Global Biologics Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Biologics Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 66. Market Position of Manufacturers in Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Biologics Production Site of Key Manufacturer
Table 68. Biologics Market: Company Product Type Footprint
Table 69. Biologics Market: Company Product Application Footprint
Table 70. Biologics New Market Entrants and Barriers to Market Entry
Table 71. Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 73. Global Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 74. Global Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Biologics Average Price by Region (2019-2024) & (USD/MT)
Table 77. Global Biologics Average Price by Region (2025-2030) & (USD/MT)
Table 78. Global Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 79. Global Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 80. Global Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Biologics Average Price by Type (2019-2024) & (USD/MT)
Table 83. Global Biologics Average Price by Type (2025-2030) & (USD/MT)
Table 84. Global Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 85. Global Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 86. Global Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Biologics Average Price by Application (2019-2024) & (USD/MT)
Table 89. Global Biologics Average Price by Application (2025-2030) & (USD/MT)
Table 90. North America Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 91. North America Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 92. North America Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 93. North America Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 94. North America Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 95. North America Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 96. North America Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 99. Europe Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 100. Europe Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 101. Europe Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 102. Europe Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 103. Europe Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 104. Europe Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 107. Asia-Pacific Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 108. Asia-Pacific Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 109. Asia-Pacific Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 110. Asia-Pacific Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 111. Asia-Pacific Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 112. Asia-Pacific Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 115. South America Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 116. South America Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 117. South America Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 118. South America Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 119. South America Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 120. South America Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 123. Middle East & Africa Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 124. Middle East & Africa Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 125. Middle East & Africa Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 126. Middle East & Africa Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 127. Middle East & Africa Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 128. Middle East & Africa Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Biologics Raw Material
Table 131. Key Manufacturers of Biologics Raw Materials
Table 132. Biologics Typical Distributors
Table 133. Biologics Typical Customers
Table 2. Global Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Eli Lilly & Company Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly & Company Major Business
Table 5. Eli Lilly & Company Biologics Product and Services
Table 6. Eli Lilly & Company Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Eli Lilly & Company Recent Developments/Updates
Table 8. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 9. Samsung Biologics Major Business
Table 10. Samsung Biologics Biologics Product and Services
Table 11. Samsung Biologics Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Samsung Biologics Recent Developments/Updates
Table 13. F Hoffman La Roche Basic Information, Manufacturing Base and Competitors
Table 14. F Hoffman La Roche Major Business
Table 15. F Hoffman La Roche Biologics Product and Services
Table 16. F Hoffman La Roche Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. F Hoffman La Roche Recent Developments/Updates
Table 18. Celltrion Basic Information, Manufacturing Base and Competitors
Table 19. Celltrion Major Business
Table 20. Celltrion Biologics Product and Services
Table 21. Celltrion Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Celltrion Recent Developments/Updates
Table 23. Addgene Basic Information, Manufacturing Base and Competitors
Table 24. Addgene Major Business
Table 25. Addgene Biologics Product and Services
Table 26. Addgene Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Addgene Recent Developments/Updates
Table 28. Amgen Basic Information, Manufacturing Base and Competitors
Table 29. Amgen Major Business
Table 30. Amgen Biologics Product and Services
Table 31. Amgen Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Amgen Recent Developments/Updates
Table 33. Abbvie Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Abbvie Inc. Major Business
Table 35. Abbvie Inc. Biologics Product and Services
Table 36. Abbvie Inc. Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Abbvie Inc. Recent Developments/Updates
Table 38. Sanofi Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Biologics Product and Services
Table 41. Sanofi Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sanofi Recent Developments/Updates
Table 43. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Inc. Major Business
Table 45. Pfizer Inc. Biologics Product and Services
Table 46. Pfizer Inc. Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Pfizer Inc. Recent Developments/Updates
Table 48. Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Merck & Co. Inc. Major Business
Table 50. Merck & Co. Inc. Biologics Product and Services
Table 51. Merck & Co. Inc. Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Merck & Co. Inc. Recent Developments/Updates
Table 53. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 54. Novo Nordisk A/S Major Business
Table 55. Novo Nordisk A/S Biologics Product and Services
Table 56. Novo Nordisk A/S Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Novo Nordisk A/S Recent Developments/Updates
Table 58. Johnson & Johnson Services Inc. Basic Information, Manufacturing Base and Competitors
Table 59. Johnson & Johnson Services Inc. Major Business
Table 60. Johnson & Johnson Services Inc. Biologics Product and Services
Table 61. Johnson & Johnson Services Inc. Biologics Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Johnson & Johnson Services Inc. Recent Developments/Updates
Table 63. Global Biologics Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 64. Global Biologics Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Biologics Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 66. Market Position of Manufacturers in Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Biologics Production Site of Key Manufacturer
Table 68. Biologics Market: Company Product Type Footprint
Table 69. Biologics Market: Company Product Application Footprint
Table 70. Biologics New Market Entrants and Barriers to Market Entry
Table 71. Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 73. Global Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 74. Global Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Biologics Average Price by Region (2019-2024) & (USD/MT)
Table 77. Global Biologics Average Price by Region (2025-2030) & (USD/MT)
Table 78. Global Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 79. Global Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 80. Global Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Biologics Average Price by Type (2019-2024) & (USD/MT)
Table 83. Global Biologics Average Price by Type (2025-2030) & (USD/MT)
Table 84. Global Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 85. Global Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 86. Global Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Biologics Average Price by Application (2019-2024) & (USD/MT)
Table 89. Global Biologics Average Price by Application (2025-2030) & (USD/MT)
Table 90. North America Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 91. North America Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 92. North America Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 93. North America Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 94. North America Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 95. North America Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 96. North America Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 99. Europe Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 100. Europe Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 101. Europe Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 102. Europe Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 103. Europe Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 104. Europe Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 107. Asia-Pacific Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 108. Asia-Pacific Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 109. Asia-Pacific Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 110. Asia-Pacific Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 111. Asia-Pacific Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 112. Asia-Pacific Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 115. South America Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 116. South America Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 117. South America Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 118. South America Biologics Sales Quantity by Country (2019-2024) & (K MT)
Table 119. South America Biologics Sales Quantity by Country (2025-2030) & (K MT)
Table 120. South America Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Biologics Sales Quantity by Type (2019-2024) & (K MT)
Table 123. Middle East & Africa Biologics Sales Quantity by Type (2025-2030) & (K MT)
Table 124. Middle East & Africa Biologics Sales Quantity by Application (2019-2024) & (K MT)
Table 125. Middle East & Africa Biologics Sales Quantity by Application (2025-2030) & (K MT)
Table 126. Middle East & Africa Biologics Sales Quantity by Region (2019-2024) & (K MT)
Table 127. Middle East & Africa Biologics Sales Quantity by Region (2025-2030) & (K MT)
Table 128. Middle East & Africa Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Biologics Raw Material
Table 131. Key Manufacturers of Biologics Raw Materials
Table 132. Biologics Typical Distributors
Table 133. Biologics Typical Customers
LIST OF FIGURES
Figure 2. Global Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biologics Consumption Value Market Share by Type in 2023
Figure 4. Monoclonal Antibodies Examples
Figure 5. Vaccines Examples
Figure 6. Recombinant Proteins Examples
Figure 7. Antisense Examples
Figure 8. RNAi Examples
Figure 9. Global Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Biologics Consumption Value Market Share by Application in 2023
Figure 11. Infectious Diseases Examples
Figure 12. Oncology Examples
Figure 13. Immunology Examples
Figure 14. Autoimmune Diseases Examples
Figure 15. Global Biologics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Biologics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Biologics Sales Quantity (2019-2030) & (K MT)
Figure 18. Global Biologics Average Price (2019-2030) & (USD/MT)
Figure 19. Global Biologics Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Biologics Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Biologics Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Biologics Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Biologics Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Biologics Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Biologics Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Biologics Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Biologics Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Biologics Average Price by Type (2019-2030) & (USD/MT)
Figure 34. Global Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Biologics Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Biologics Average Price by Application (2019-2030) & (USD/MT)
Figure 37. North America Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Biologics Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Biologics Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Biologics Consumption Value Market Share by Region (2019-2030)
Figure 57. China Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Biologics Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Biologics Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Biologics Market Drivers
Figure 78. Biologics Market Restraints
Figure 79. Biologics Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Biologics in 2023
Figure 82. Manufacturing Process Analysis of Biologics
Figure 83. Biologics Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 2. Global Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biologics Consumption Value Market Share by Type in 2023
Figure 4. Monoclonal Antibodies Examples
Figure 5. Vaccines Examples
Figure 6. Recombinant Proteins Examples
Figure 7. Antisense Examples
Figure 8. RNAi Examples
Figure 9. Global Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Biologics Consumption Value Market Share by Application in 2023
Figure 11. Infectious Diseases Examples
Figure 12. Oncology Examples
Figure 13. Immunology Examples
Figure 14. Autoimmune Diseases Examples
Figure 15. Global Biologics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Biologics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Biologics Sales Quantity (2019-2030) & (K MT)
Figure 18. Global Biologics Average Price (2019-2030) & (USD/MT)
Figure 19. Global Biologics Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Biologics Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Biologics Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Biologics Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Biologics Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Biologics Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Biologics Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Biologics Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Biologics Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Biologics Average Price by Type (2019-2030) & (USD/MT)
Figure 34. Global Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Biologics Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Biologics Average Price by Application (2019-2030) & (USD/MT)
Figure 37. North America Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Biologics Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Biologics Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Biologics Consumption Value Market Share by Region (2019-2030)
Figure 57. China Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Biologics Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Biologics Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Biologics Market Drivers
Figure 78. Biologics Market Restraints
Figure 79. Biologics Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Biologics in 2023
Figure 82. Manufacturing Process Analysis of Biologics
Figure 83. Biologics Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
More Publications
Asia-Pacific Wound Care Biologics Market by Manufacturers, Regions, Type and Application, Forecast to 2022
US$ 4,480.00
August 2017
115 pages
Global Wound Care Biologics Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
January 2026
170 pages
Global Biological Safety Cabinet Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
January 2025
120 pages
Global Wound Biologics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
June 2022
101 pages
Global Biologic Imaging Reagents Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
July 2022
90 pages
